The cost-analysis presented by Sharma et al 1 reported that a community model, where patients were monitored by 'accredited' optometrists, was more than double the cost of a hospital-based service. Notwithstanding concern that the community service did not use clinicians with specialist training and a glaucoma qualification awarded by the appropriate professional body as demanded by NICE, the results were surprising to the authors of this reply who are optometrists with a specialist glaucoma qualification and independent prescribing status because we offer private glaucoma services in community at separate locations within the UK at a much lower cost than estimated. We would like to suggest why the model does not agree with reality.
The community model was based on the appointment structure of sight tests that involve refraction, with only 11 patients being seen per day. In contrast, it is typical for optometrists working in hospital glaucoma clinics to have a daily caseload of 20 patients. We have been told by an author of the study that this reflected the inclusion of 'non-stable' cases (Professor Lawrenson, personal communication), but remain unconvinced that such a large reduction in volume is needed. The opportunity cost to optometrists relative to their usual business of providing sight tests and selling spectacles was used as a surrogate for the cost of providing glaucoma services. A wide range of values have been reported for this figure, which is not unexpected given the large variation in overheads and retail income. Recently, in a joint publication by the main optical bodies, it was estimated that the daily cost of running a practice was d910-1225, 2 which is less than the d1601.81 suggested by optometrists involved in this study. The inflated opportunity cost in this study may reflect the relatively high-rental rates and retail income in London, but their disagreement with other reports indicates that they may not be applicable to other regions. If the community costs suggested by the main optical bodies and the typical daily caseload of 20 patients are used, we have a cost per visit of d45.50-61.25, which is much less than the d145.62 reported.
Insufficient details were given in the paper to allow for an opinion on the validity of cost estimates of the hospital-based glaucoma service, but of more relevance is the fact that hospital services in the UK use a fixed tariff system and so from the view of the funding body no estimate is needed. The 2010/2011 outpatient attendance allowance for ophthalmology was d67 for follow-up attendance (WF01A) and the market forces factor for Ealing Hospital NHS Trust was 1.197 , and so we calculate that the real cost per visit to the funding body was d80.18. 3 We doubt that hospitals are prepared to work for less than this opportunity cost.
Comment
The discrepancy between the study results and our experiences shows that the cost of a particular model of community-based glaucoma services cannot be generalized to all community-based glaucoma services. It is also important to appreciate that optometrists working in community can improve accessibility and increase capacity of glaucoma services, which is relevant in the context of the typically elderly glaucoma population and increasing appointment delays that have already led to avoidable sight loss.
